ifosfamide has been researched along with Adenocarcinoma, Mucinous in 3 studies
Adenocarcinoma, Mucinous: An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tanaka, N | 1 |
| Matsui, H | 1 |
| Nagai, Y | 1 |
| Suzuka, K | 1 |
| Seki, K | 1 |
| Sekiya, S | 1 |
| Zylberberg, B | 1 |
| Dormont, D | 1 |
| Madelenat, P | 1 |
| Daraï, E | 1 |
| Fruscio, R | 1 |
| Colombo, N | 1 |
| Lissoni, AA | 1 |
| Garbi, A | 1 |
| Fossati, R | 1 |
| Ieda', N | 1 |
| Torri, V | 1 |
| Mangioni, C | 1 |
2 trials available for ifosfamide and Adenocarcinoma, Mucinous
| Article | Year |
|---|---|
First-line intraperitoneal cisplatin-paclitaxel and intravenous ifosfamide in Stage IIIc ovarian epithelial cancer.
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Ca | 2004 |
A phase II randomised clinical trial comparing cisplatin, paclitaxel and ifosfamide with cisplatin, paclitaxel and epirubicin in newly diagnosed advanced epithelial ovarian cancer: long-term survival analysis.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adult; Aged; Antineoplastic Combined Chemother | 2008 |
1 other study available for ifosfamide and Adenocarcinoma, Mucinous
| Article | Year |
|---|---|
Impact of maintenance chemotherapy on disease-free survival in patients with stage Ic and II epithelial ovarian cancer.
Topics: Adenocarcinoma, Clear Cell; Adenocarcinoma, Mucinous; Adolescent; Adult; Aged; Antineoplastic Combin | 2002 |